Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Dividends Paid - Common (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of Dividends Paid - Common data on record, last reported at $988000.0 in Q3 2025.

  • For Q3 2025, Dividends Paid - Common fell 6.08% year-over-year to $988000.0; the TTM value through Sep 2025 reached $4.0 million, down 5.8%, while the annual FY2024 figure was $4.3 million, 0.51% down from the prior year.
  • Dividends Paid - Common reached $988000.0 in Q3 2025 per UTMD's latest filing, down from $1.0 million in the prior quarter.
  • Across five years, Dividends Paid - Common topped out at $8.3 million in Q4 2021 and bottomed at $988000.0 in Q3 2025.
  • Average Dividends Paid - Common over 5 years is $1.5 million, with a median of $1.1 million recorded in 2022.
  • Peak YoY movement for Dividends Paid - Common: skyrocketed 719.33% in 2021, then crashed 87.41% in 2022.
  • A 5-year view of Dividends Paid - Common shows it stood at $8.3 million in 2021, then crashed by 87.41% to $1.1 million in 2022, then increased by 1.9% to $1.1 million in 2023, then fell by 3.08% to $1.0 million in 2024, then decreased by 4.82% to $988000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Dividends Paid - Common were $988000.0 in Q3 2025, $1.0 million in Q2 2025, and $1.0 million in Q1 2025.